Promotion of Breast Milk Donation in Breastfeeding Mothers Through a Mobile Health Intervention Using Amamantapp

In Peru, 7 out of 10 preterm babies die due to health complications. These newborns often cannot be breastfed by their own mothers and urgently need donated breast milk (BM) to survive. Human Milk Banks help to reduce mortality among preterm babies, but there are currently not enough donors to meet the high demand. Many mothers do not donate because they lack clear information or have concerns based on perceptions, beliefs, and attitudes that influence their predisposition to donate. The researchers had developed an innovative technological tool (ITT) called Amamantapp, a mobile application, to promote BM donation using the Design Thinking methodology to identify participants' needs, prioritize topics to be managed, and define the most appropriate ITT. The goal of this clinical trial is to evaluate the effect of Amamantapp on the promotion of breast milk donation in breastfeeding mothers within 40 days of giving birth who are treated at the the National Maternal and Perinatal Hospital in Lima, Peru. The main questions it aims to answer are: * Does the intervention using a technological tool raise the level of knowledge about breast milk donation among breastfeeding mothers? * Does the intervention boost the attitude toward breast milk donation in breastfeeding mothers? * Does the intervention raise the proportion of breastfeeding mothers who start breast milk donation practices? Participants will be randomly assigned to either an intervention group, which will use the technological tool for 60 days, or a control group. Researchers will measure changes in knowledge, attitudes, and practices (KAP) using a KAP questionnaire before and after the intervention period.

NCT Number	NCT07477041
Lead Sponsor	National University of San Marcos, Peru
Conditions	Health Knowledge Attitudes and Practice, Breast Feeding
Enrollment	112 participants
Start Date	2024-04-01
Primary Completion	2024-06-30 (estimated)
Study Completion	2024-12-30 (estimated)
Updated on ClinicalTrials.gov	2026-03-19